Causeway Therapeutics Ltd — Form D

Causeway Therapeutics Ltd of GLASGOW, X0, a company, filed a Form D exempt-offering notice with the SEC on 2023-02-28. The offering totals $14.3M, of which $14.3M was reported sold. Industry: Biotechnology.

Offering

• Filed: 2023-02-28
• Form: D
• Accession: 0001515971-23-000017
• Industry: Biotechnology
• Exemptions: 06b
• Total offering: $14.3M
• Amount sold: $14.3M
• Investors: 10
• Date of first sale: 2023-02-03
• Security types: equity
• Revenue range: Decline to Disclose
• SEC file number: 021-474432

Issuer

• Name: Causeway Therapeutics Ltd
• CIK: 0001966914
• Entity type: Corporation
• Jurisdiction: UNITED KINGDOM
• Address: C/O IMAGING CENTRE OF EXCELLENCE, GLASGOW, X0, G51 4TF
• Phone: 441414516822

Officers, directors & promoters (9)

More

• CIK 1966914 on SEC EDGAR (source of record)
• This page as markdown (for LLM agents)
• Search all SEC filings, advisers and people on Adviser Search